rss
Ann Rheum Dis 2007;66:458-463 doi:10.1136/ard.2006.054734
  • Extended report

Resistin in rheumatoid arthritis synovial tissue, synovial fluid and serum

  1. L Šenolt1,
  2. D Housa2,
  3. Z Vernerová2,
  4. T Jirásek2,
  5. R Svobodová1,
  6. D Veigl3,
  7. K Anderlová4,
  8. U Müller-Ladner5,
  9. K Pavelka1,
  10. M Haluzík4
  1. 1Institute of Rheumatology, 1st Medical Faculty, Charles University, Prague, Czech Republic
  2. 2Department of Pathology, 1st Medical Faculty, Charles University, Prague, Czech Republic
  3. 3Clinic of Orthopaedic Surgery, 1st Medical Faculty, Charles University, Prague, Czech Republic
  4. 43rd Department of Medicine, 1st Medical Faculty, Charles University, Prague, Czech Republic
  5. 5University Hospital Giessen, Department of Internal Medicine and Rheumatology, Division of Rheumatology and Clinical Immunology, Giessen, Germany
  1. Correspondence to:
    Dr L Šenolt
    Institute of Rheumatology, Na Slupi 4, 12850 Prague 2, Czech Republic; seno{at}revma.cz
  • Accepted 9 October 2006
  • Published Online First 13 October 2006

Abstract

Background: Resistin is a newly identified adipocytokine which has demonstrated links between obesity and insulin resistance in rodents. In humans, proinflammatory properties of resistin are superior to its insulin resistance-inducing effects.

Objectives: To assess resistin expression in synovial tissues, serum and synovial fluid from patients with rheumatoid arthritis, osteoarthritis and spondylarthropathies (SpA), and to study its relationship with inflammatory status and rheumatoid arthritis disease activity.

Methods: Resistin expression and localisation in synovial tissue was determined by immunohistochemistry and confocal microscopy. Serum and synovial fluid resistin, leptin, interleukin (IL)1β, IL6, IL8, tumour necrosis factor α, and monocyte chemoattractant protein-1 levels were measured. The clinical activity of patients with rheumatoid arthritis was assessed according to the 28 joint count Disease Activity Score (DAS28).

Results: Resistin was detected in the synovium in both rheumatoid arthritis and osteoarthritis. Staining in the sublining layer was more intensive in patients with rheumatoid arthritis compared with those with osteoarthritis. In rheumatoid arthritis, macrophages (CD68), B lymphocytes (CD20) and plasma cells (CD138) but not T lymphocytes (CD3) showed colocalisation with resistin. Synovial fluid resistin was higher in patients with rheumatoid arthritis than in those with SpA or osteoarthritis (both p<0.001). In patients with rheumatoid arthritis and SpA, serum resistin levels were higher than those with osteoarthritis (p<0.01). Increased serum resistin in patients with rheumatoid arthritis correlated with both CRP (r = 0.53, p<0.02), and DAS28 (r = 0.44, p<0.05), but not with selected (adipo) cytokines.

Conclusion: The upregulated resistin at local sites of inflammation and the link between serum resistin, inflammation and disease activity suggest a role for resistin in the pathogenesis of rheumatoid arthritis.

Footnotes

  • Published Online First 22 November 2006

  • Competing interests: None declared.

This Article

  1. Abstract
  2. Full text
  3. PDF
  4. All versions of this article:
    1. ard.2006.054734v1
    2. ard.2006.054734v2
    3. ard.2006.054734v3
    4. ard.2006.054734v4
    5. 66/4/458 most recent

Responses

  1. Submit a response
  2. No responses published

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.